Lantheus Holdings (LNTH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Lantheus Holdings (LNTH)
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Key Insights
Critical company metrics and information
Share Price
$89.02Market Cap
$6.19 BillionTotal Outstanding Shares
69.53 Million SharesTotal Employees
834Dividend
No dividendIPO Date
June 25, 2015SIC Description
In Vitro & In Vivo Diagnostic SubstancesHomepage
https://www.lantheus.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-231.48 Million |
Net Cash Flow From Operating Activities, Continuing | $499.31 Million |
Net Cash Flow From Investing Activities, Continuing | $-231.48 Million |
Net Cash Flow From Financing Activities | $-15.33 Million |
Net Cash Flow From Operating Activities | $499.31 Million |
Net Cash Flow | $252.30 Million |
Net Cash Flow, Continuing | $252.50 Million |
Exchange Gains/Losses | $198000.00 |
Net Cash Flow From Financing Activities, Continuing | $-15.33 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Operating Expenses | $489.02 Million |
Net Income/Loss Attributable To Parent | $427.61 Million |
Costs And Expenses | $926.64 Million |
Revenues | $1.50 Billion |
Net Income/Loss | $427.61 Million |
Other Operating Expenses | $339.43 Million |
Basic Earnings Per Share | $6.21 |
Income/Loss From Continuing Operations After Tax | $427.61 Million |
Basic Average Shares | $207.66 Million |
Income/Loss From Continuing Operations Before Tax | $570.16 Million |
Cost Of Revenue | $527.18 Million |
Research and Development | $149.60 Million |
Operating Income/Loss | $480.59 Million |
Net Income/Loss Available To Common Stockholders, Basic | $427.61 Million |
Benefits Costs and Expenses | $926.64 Million |
Income Tax Expense/Benefit | $142.55 Million |
Diluted Earnings Per Share | $6.00 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Gross Profit | $969.62 Million |
Diluted Average Shares | $213.73 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Intangible Assets | $173.61 Million |
Equity Attributable To Parent | $1.18 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Fixed Assets | $169.51 Million |
Current Assets | $1.30 Billion |
Liabilities And Equity | $2.05 Billion |
Noncurrent Assets | $753.92 Million |
Other Current Assets | $1.22 Billion |
Wages | $35.74 Million |
Liabilities | $869.92 Million |
Current Liabilities | $784.08 Million |
Inventory | $70.83 Million |
Accounts Payable | $44.91 Million |
Assets | $2.05 Billion |
Noncurrent Liabilities | $85.84 Million |
Equity | $1.18 Billion |
Other Current Liabilities | $703.42 Million |
Other Non-current Assets | $410.80 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.